Product Name |
6-hydroxycannabidiol-d9 |
Alternate Names |
cannabidiol Stable Isotopes, Stable Isotopes of cannabidiol |
CAT No. |
CS-B-00262
|
CAS No. |
63958-73-6 (unlabelled) |
Category |
Stable Isotopes |
Stock |
Enquire
|
Mol. Wt. |
339.51 g/mol |
Mol. For. |
C21H21D9O3
|
Hazardous |
This is not a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
cannabidiol |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
6-Hydroxycannabidiol-d9 (6-OH-CBD-d9) is a derivative of cannabidiol (CBD), a non-psychoactive component of the cannabis plant. It is labeled with deuterium, a stable isotope of hydrogen, which allows for its use in research and analytical applications.
This compound has been found to have potential therapeutic benefits for a variety of conditions, including anxiety, epilepsy, and chronic pain. It works by interacting with the body's endocannabinoid system, which regulates many physiological processes such as mood, appetite, and sleep.
In terms of chemical information, 6-OH-CBD-d9 has a molecular formula of C21H29D9O3 and a molecular weight of 365.6 g/mol. It has a melting point of approximately 60-62°C and a boiling point of approximately 505°C.
It is important to note that 6-OH-CBD-d9 is a controlled substance and its use is restricted to authorized research purposes only. It should be handled with caution and in compliance with all applicable regulations.
Overall, 6-OH-CBD-d9 is an important compound for the study of CBD and its potential therapeutic effects. Its stable isotope labeling allows for accurate analysis and quantification, and its interaction with the endocannabinoid system holds promise for future research and development of CBD-based therapies.